Ronghua Yang

Ronghua Yang

Cardiology

1825 Eastchester Road
Bronx, NY 10467

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

AI-ICE Guided Pulsed Field Ablation of Atrial Fibrillation with Variable Loop Circular Catheter.

AI-ICE Guided Pulsed Field Ablation of Atrial Fibrillation with Variable Loop Circular Catheter.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: April 21, 2026

MRS2339, a cardiac P2X4 receptor nucleotide activator, improves systolic function in heart failure.

MRS2339, a cardiac P2X4 receptor nucleotide activator, improves systolic function in heart failure.

Journal: Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

Published: February 02, 2026

Extravascular implantable cardioverter-defibrillator implantation in a patient with nickel and cobalt allergies.

Extravascular implantable cardioverter-defibrillator implantation in a patient with nickel and cobalt allergies.

Journal: HeartRhythm case reports

Published: December 03, 2025

Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE).

Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE).

Journal: American journal of respiratory and critical care medicine

Published: March 05, 2025

Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlled trial.

Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlled trial.

Journal: The journal of headache and pain

Published: November 11, 2020

Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials.

Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials.

Journal: The journal of headache and pain

Published: October 06, 2020

Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study.

Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study.

Journal: The journal of headache and pain

Published: June 26, 2020

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study.

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study.

Journal: The journal of headache and pain

Published: June 22, 2020

No "Wearing-Off Effect" Seen in Quarterly or Monthly Dosing of Fremanezumab: Subanalysis of a Randomized Long-Term Study.

No "Wearing-Off Effect" Seen in Quarterly or Monthly Dosing of Fremanezumab: Subanalysis of a Randomized Long-Term Study.

Journal: Headache

Published: June 19, 2020

Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine.

Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine.

Journal: Cephalalgia : an international journal of headache

Published: November 23, 2019

Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study.

Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study.

Journal: Neurology

Published: October 10, 2019

Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine.

Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine.

Journal: Headache

Published: August 27, 2019

Showing 1-12 of 43

Last Updated: 09/26/2026